“…These hopes did not materialize. The practical value of antiphlogistic hormone treatment, as it is now practised, is limited by its undesirable side-efTccts and many experienced clinicians recom mend that they be not used routinely, even in the treatment of rheumatoid arthritis where they were supposed to be most useful (3,14,21). Of course, they will continue to be valuable additions to our therapeutic armamentarium.…”